William P Fay Selected Research

William P Fay Research Topics

Disease

16	Thrombosis (Thrombus) 03/2012 - 01/2002
5	Vascular Diseases (Vascular Disease) 11/2016 - 09/2005
5	Hyperplasia 11/2016 - 07/2004
4	Atherosclerosis 01/2022 - 07/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 07/2021 - 07/2013
4	Inflammation (Inflammations) 01/2020 - 11/2010
4	Neointima 11/2016 - 06/2002
4	Carotid Artery Injuries 10/2009 - 03/2002
3	Ischemia 01/2021 - 09/2011
3	Vascular System Injuries 11/2016 - 05/2003
2	Carcinoma (Carcinomatosis) 01/2021 - 07/2015
2	Neoplasms (Cancer) 01/2021 - 07/2015
2	Atherosclerotic Plaque (Atheroma) 01/2020 - 08/2011
2	Obesity 01/2020 - 01/2019
2	Vascular Remodeling 11/2016 - 09/2005
2	Myocardial Infarction 07/2013 - 07/2002
1	Infections 01/2022
1	Reperfusion Injury 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Hyperglycemia 01/2020
1	Glucose Intolerance 01/2019
1	Hypertension (High Blood Pressure) 05/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2015
1	Venous Thromboembolism 07/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2013
1	Diabetes Mellitus 07/2013
1	Infarction (Infarctions) 08/2011
1	Rupture 08/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2011
1	Hemorrhage 11/2004
1	Streptococcal Infections (Streptococcal Infection) 08/2004
1	Iron Overload 05/2003

Drug/Important Bio-Agent (IBA)

9	Plasminogen Activator Inhibitor 1IBA 01/2021 - 06/2002
5	Plasminogen Activators (Plasminogen Activator)IBA 01/2020 - 06/2002
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
3	tiplaxtininIBA 01/2020 - 07/2015
3	Thrombin FDA Link 08/2011 - 01/2002
3	VitronectinIBA 08/2011 - 06/2002
2	Virulence Factors (Pathogenicity Factors)IBA 01/2022 - 08/2004
2	Fish OilsIBA 07/2021 - 05/2021
2	LDL Receptors (LDL Receptor)IBA 01/2020 - 03/2006
2	Pharmaceutical PreparationsIBA 11/2016 - 11/2004
2	FibrinIBA 08/2011 - 07/2004
2	C-Reactive ProteinIBA 11/2010 - 08/2003
2	ferric chlorideIBA 09/2010 - 09/2007
2	Peptide Hydrolases (Proteases)FDA Link 10/2009 - 09/2005
2	Thromboplastin (Tissue Factor)IBA 03/2006 - 01/2005
2	CollagenIBA 09/2005 - 08/2004
2	AnticoagulantsIBA 11/2004 - 07/2002
2	PlasminogenIBA 08/2004 - 07/2002
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2022
1	GW 4869IBA 01/2022
1	Caveolin 2IBA 01/2021
1	CholesterolIBA 01/2020
1	LipidsIBA 01/2020
1	Sucrose (Saccharose)IBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Vasoconstrictor AgentsIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Endothelin-1 (Endothelin 1)IBA 01/2019
1	Janus KinasesIBA 11/2016
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 11/2016
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 11/2016
1	setanaxibIBA 05/2016
1	Interleukin-18 (Interleukin 18)IBA 05/2016
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 03/2016
1	GoldIBA 03/2016
1	Bevacizumab (Avastin)FDA Link 07/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2015
1	Plasminogen InactivatorsIBA 07/2015
1	Monoclonal AntibodiesIBA 07/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2013
1	Oxidoreductases (Dehydrogenase)IBA 07/2013
1	HomocysteineIBA 03/2012
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2011
1	sodium bisulfide (NaHS)IBA 09/2011
1	AntithrombinsIBA 08/2011
1	Biomarkers (Surrogate Marker)IBA 11/2010
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 09/2010
1	Pancreatic Elastase (Elastase)IBA 10/2009
1	Fibrinolysin FDA Link 06/2007
1	ApolipoproteinsIBA 03/2006
1	Apolipoproteins E (ApoE)IBA 03/2006
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 09/2005
1	factor V LeidenIBA 12/2004
1	AntidotesIBA 11/2004
1	Streptokinase FDA Link 08/2004
1	Heme Oxygenase-1IBA 08/2004
1	Dextrans (Dextran)FDA Link 05/2003
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2003
1	Cysteine (L-Cysteine)FDA Link 05/2003
1	IronIBA 05/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2003

Therapy/Procedure

2	Ligation 01/2005 - 06/2002
1	Glycemic Control 01/2019
1	Drug-Eluting Stents 03/2016
1	Secondary Prevention 07/2013
1	Intraperitoneal Injections 10/2009
1	Transplantation 01/2005